Study Shows That Immune System Holds Clues To Patients With High-risk Smoldering Myeloma Likely To Benefit From Treatment

Press/Media

Period	1 Dec 2022

Media coverage

Title	Study Shows That Immune System Holds Clues To Patients With High-risk Smoldering Myeloma Likely To Benefit From Treatment
Media name/outlet	OncLive
Country/Territory	United States
Date	1/12/22
URL	https://www.onclive.com/view/study-shows-that-immune-system-holds-clues-to-patients-with-high-risk-smoldering-myeloma-likely-to-benefit-from-treatment
Persons	Tarek Mouhieddine